Full Text View
Tabular View
Study Results
Related Studies
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
This study has been completed.
Study NCT01194830   Information provided by Boehringer Ingelheim

First Received on September 2, 2010.   Last Updated on December 12, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial